These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19816806)

  • 1. Shaping the science-industry-policy interface in synthetic biology.
    Gaisser S; Reiss T
    Syst Synth Biol; 2009 Dec; 3(1-4):109-14. PubMed ID: 19816806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intellectual property rights, standards and data exchange in systems biology: Reflections from the IP Expert Meeting at the University of Luxembourg, 8-9 October 2015, ERASysAPP - ERA-Net for Systems Biology Applications.
    van Zimmeren E; Rutz B; Minssen T
    Biotechnol J; 2016 Dec; 11(12):1477-1480. PubMed ID: 27966844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The attitudes of religious, environmental, and science policy leaders toward biotechnology.
    Miller JD
    Recomb DNA Tech Bull; 1985 Dec; 8(4):141-64. PubMed ID: 4095277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactive learning and action: realizing the promise of synthetic biology for global health.
    Betten AW; Roelofsen A; Broerse JE
    Syst Synth Biol; 2013 Sep; 7(3):127-38. PubMed ID: 24432150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Private and public values of innovation: A patent analysis of synthetic biology.
    Ribeiro B; Shapira P
    Res Policy; 2020 Feb; 49(1):103875. PubMed ID: 32015589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, security, and serving the public interest in synthetic biology.
    Gronvall GK
    J Ind Microbiol Biotechnol; 2018 Jul; 45(7):463-466. PubMed ID: 29560534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic biology advances and applications in the biotechnology industry: a perspective.
    Katz L; Chen YY; Gonzalez R; Peterson TC; Zhao H; Baltz RH
    J Ind Microbiol Biotechnol; 2018 Jul; 45(7):449-461. PubMed ID: 29915997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safe and Sound? Scientists' Understandings of Public Engagement in Emerging Biotechnologies.
    Braun M; Starkbaum J; Dabrock P
    PLoS One; 2015; 10(12):e0145033. PubMed ID: 26660160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Defence of Artificial Life by Synthetic Biology From Ethical and Social Aspects.
    Chen Y; Yin Z; Shao Z; Xie Q
    J Coll Physicians Surg Pak; 2015 Jul; 25(7):519-24. PubMed ID: 26208557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contextualizing Security Innovation: Responsible Research and Innovation at the Smart Border?
    Klimburg-Witjes N; Huettenrauch FC
    Sci Eng Ethics; 2021 Feb; 27(1):13. PubMed ID: 33599880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intellectual property rights in synthetic biology: an anti-thesis to open access to research?
    Saukshmya T; Chugh A
    Syst Synth Biol; 2010 Dec; 4(4):241-5. PubMed ID: 22132050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic genome engineering forging new frontiers for wine yeast.
    Pretorius IS
    Crit Rev Biotechnol; 2017 Feb; 37(1):112-136. PubMed ID: 27535766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A priority paper for the societal and ethical aspects of synthetic biology.
    Schmidt M; Ganguli-Mitra A; Torgersen H; Kelle A; Deplazes A; Biller-Andorno N
    Syst Synth Biol; 2009 Dec; 3(1-4):3-7. PubMed ID: 19816794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constructing future scenarios as a tool to foster responsible research and innovation among future synthetic biologists.
    Betten AW; Rerimassie V; Broerse JEW; Stemerding D; Kupper F
    Life Sci Soc Policy; 2018 Sep; 14(1):21. PubMed ID: 30198056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project.
    Edmunds LD; Gluderer S; Ovseiko PV; Kamerling R; Ton J; Vis L; Jenni M; Tutton G; Lawton-Smith H; Nadabán MV; Rab M; Rees J; Anson J; Rushforth AD; Allen M; Buchan AM; Vendrell M; Casta A; Mehes G; Hogendoorn PCW; Hafen E; Hassan AB
    Health Res Policy Syst; 2019 Jan; 17(1):10. PubMed ID: 30691504
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.